Two Sigma Investments, LP Morpho Sys Ag Transaction History

Two Sigma Investments, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.6 - $18.18 $627,542 - $1.33 Million	-72,970 Reduced 39.25%	112,957 $2.05 Million
Q4 2023 Feb 14, 2024	BUY	$4.55 - $9.9 $845,967 - $1.84 Million	185,927 New	185,927 $1.84 Million
Q2 2023 Aug 14, 2023	BUY	$3.95 - $7.74 $98,560 - $193,128	24,952 New	24,952 $186,000
Q1 2022 May 16, 2022	SELL	$5.87 - $9.73 $291,322 - $482,890	-49,629 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $237,405 - $325,517	26,146 Added 111.34%	49,629 $468,000
Q3 2021 Nov 15, 2021	SELL	$11.76 - $19.51 $168,614 - $279,734	-14,338 Reduced 37.91%	23,483 $276,000
Q2 2021 Aug 16, 2021	BUY	$18.95 - $23.95 $716,707 - $905,812	37,821 New	37,821 $728,000
Q4 2019 Feb 14, 2020	SELL	$26.07 - $36.32 $198,705 - $276,831	-7,622 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$24.18 - $31.58 $184,299 - $240,702	7,622 New	7,622 $209,000
Q1 2019 May 15, 2019	SELL	$22.55 - $29.84 $194,110 - $256,862	-8,608 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$21.96 - $31.02 $189,031 - $267,020	8,608 New	8,608 $217,000
Q3 2018 Nov 14, 2018	SELL	$26.64 - $35.66 $259,393 - $347,221	-9,737 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $244,885 - $297,952	9,737 New	9,737 $295,000

1.8M

14.7K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.